Single blind, multicentre, randomized, controlled trial testing the effects of a novel nutraceutical compound on plasma lipid and cardiovascular risk factors: Results of the interim analysis
Nutrition, metabolism, and cardiovascular diseases : NMCD | 3 Oct 2017
V Trimarco, A Battistoni, G Tocci, R Coluccia, MV Manzi, R Izzo and M Volpe
The clustering of high levels of LDL cholesterol (LDL-C) and other risk factors represents a predisposing condition for atherosclerotic disease development. Cardiovascular prevention is based on effective control of these conditions. In adult subjects with mild hypercholesterolemia we compared in the real life the effects of a new combination of nutraceuticals on lipid and glucose metabolism and blood pressure with those of an established nutraceutical combination.
* Data courtesy of Altmetric.com